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Spinal anesthesiaAbstract Objectives: The purpose of our study was to evaluate the prophylactic use of low dose
ketamine and comparing it to dexamethasone for reducing intraoperative nausea and vomiting
(IONV) during cesarean section under spinal anesthesia.
Methods: The study was performed in 135 full term parturient women of ASA I & II (American
Society of Anesthesiology Grade I & II), aged between 20 and 40 years with uncomplicated preg-
nancies. The group I (n= 45) received 0.4 mg/kg ketamine, group II (n= 45) received 8 mg dexa-
methasone while control group III (n= 45) received 5 ml normal saline, slowly IV immediately
after spinal anesthesia and before surgical incision. The number of episodes of nausea and vomiting
was recorded, as well as any other adverse effects.
Results: The results of this study showed that the rate of nausea and vomiting was lower in patients
who received 0.4 mg/kg ketamine and 8 mg dexamethasone than in the placebo group with signif-
icant reduction in hypotensive episodes in ketamine group (P= 0.02).
Conclusion: Low dose ketamine is effective as dexamethasone in prevention of IONV during cesar-
ean section under spinal anesthesia.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Nausea and vomiting is seen in almost 80% of the patients
undergoing cesarean section (CS) under regional anesthesia
[1–3]. Many factors may contribute to this high rate of IONV
during CS; sympathetic block and the resultant hypotensionsecondary to spinal anesthesia, visceral pain and vagal stimu-
lation during CS probably the most important factors [4].
Dexamethasone is an effective antiemetic agent with minimal
side effects after single dose administration. [5]. Ketamine
has unique central sympatho-mimetic, vagolytic and analgesic
properties [8]. These effects of ketamine are assumed to reduce
the incidence of spinal induced hypotension and consequently
nausea and vomiting. In this study, we aimed to compare the
antiemetic efﬁcacy of low dose ketamine and dexamethasone
to decrease the incidence of IONV during CS under spinal
anesthesia.
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After obtaining approval from the clinical research ethics
committee of Al-Minia University, all participants provided
a written informed consent. This randomized, prospective,
double blind, study was performed on 135 ASA physical status
I–II female patients, between 20 and 40 years of age undergo-
ing a planned CS under spinal anesthesia. We exclude patients
with, preeclampsia, eclampsia, psychiatric disorder, a gastroin-
testinal disease, drug allergies, infection, diabetes, glaucoma,
epileptic patients, and those on antiemetic agent in the last
24 h. All parturients received 1000 ml lactated Ringer solution
IV over 30 min before spinal injection. Patients connected to
standard monitoring includes electrocardiogram, noninvasive
arterial blood pressure measurement and pulse oximetry
(MARQUERR, SOLAR 8000, Patient monitor, UK). Spinal
anesthesia performed using a 25-gauge spinal needle (GHAT-
WARYMEDICAL SUPPLY, EGYPT), while the patient is in
the sitting position, through the L3-4, L4-5 or L2-3 interspace
2.2–2.8 ml (depending on patients height) of 0.5% heavy
marcaine (Marcaine Spinal Heavy Ampul 0.5%, Astrazeneca)
was administered to the subarachnoid space. Parturients were
moved to supine position with operation table turned 15–
20 deg left lateral tilt to decrease the aortocaval compression
caused by the uterus and reducing hypotension after spinal
anesthesia. The parturients were allocated randomly to three
groups, ketamine group (n= 45) received 0.4 mg/kg ketamine
diluted in 5 ml normal saline, dexamethasone group (n= 45)
received 8 mg dexamethasone diluted in 5 ml normal saline
and control group (n= 45) received 5 ml normal saline, the
three syringes were given by the second anesthetist to the anes-
thetist who was unaware of the content of the syringe and
would administer it in a double-blind fashion slowly IV over
1 min before surgical incision. Face mask oxygenation used
to all patients at a rate of 2–3 L/min, the level of sensory block-
age was evaluated by pinprick test before the surgical incision,
and the level of blockade was determined. We exclude from the
study Patients in whom the level of analgesia was insufﬁcient,
and were given general anesthesia. Estimated ﬂuid deﬁcits and
maintenance requirements were replaced with lactated
Ringer’s solution IV, intraoperative hypotension (MABP less
than 20% of the basal reading) was managed by increasing
the infusion rate of Ringer lactate solution with injecting incre-
ments of 3 mg ephedrine hydrochloride IV and if hypotension
persists another ephedrine bolus was given. Bradycardia
(HR< 50 beat/min) managed by atropine sulfate (0.5 mg).
After delivery of the baby, routine use of 10 units oxytocin
IV and 0.2 mg ergometrine IM were given to all parturient
to enhance uterine contraction. We recorded the incidence of
hypotension (percentage per each group) and increments of
ephedrine hydrochloride in mg. During the intraoperative per-
iod, nausea, retching and vomiting episodes were recorded by
an anesthetist who was blinded to the drug administered to the
patient, questioning the patient in every 3 min about these
emetic symptoms, the patient was also requested to report
the symptoms that occur at the intervals. Vomiting was man-
aged by metoclopramide 10 mg slowly IV, and analgesic
requirements (fentanyl) 20–50 lg that injected IV when needed
after delivery of the baby and the amount recorded. A stan-
dardized surgical technique was used in all cesarean section’s
except for the tubal ligation procedure performed in somebut not all of the cases. Ramsay Sedation Scale (RSS; 1 = anx-
ious and agitated, 2 = co-operative and tranquil, 3 = drowsy
but responsive to command, 4 = asleep but responsive to gla-
bellar tap, 5 = asleep with a sluggish response to tactile stim-
ulation, 6 = asleep and no response). It was used to measure
sedation level at 5, 10, 20, and 30 min after surgical incision.
2.1. Statistical analysis
The statistical analysis was done using SPSS program statisti-
cal package for social science version 16 (SPSS Inc., Chicago,
USA). At two-tailed signiﬁcance level of 0.05% and power of
80%, it was calculated that a minimum sample size of 43
patients in each group was required to achieve 30% reduction
in the total incidence of intraoperative nausea and vomiting
(from 60% to 30%), thus 45 patients were enrolled in the pres-
ent study to receive each drug for prevention of intraoperative
nausea and vomiting. Data values were expressed as frequency
(%) or means ± standard deviation (SD), as appropriate. Stu-
dent t-test was used to compare between three groups of nor-
mally distributed data. Chi square test was used for qualitative
data. Mann–Whitney test was used to compare three groups of
non parametric data. P-value was signiﬁcant if it is <0.05.
3. Results
There were no statistically signiﬁcant differences in age, height,
weight, gestational age, history of PONV, history of vertigo or
baseline hemodynamics between the studied three groups
(Table 1). We exclude three cases from the study due to incom-
plete block (below T10) one in each group. Intraoperatively,
there were no differences in anesthesia time, operating time,
total ephedrine administered (the average amount in those
who suffered hypotension and received ephedrine), total fenta-
nyl administered (average for each patient), hypotensive epi-
sodes (number of patients who suffered from hypotension)
between ketamine and dexamethazone groups, while the con-
trol group showed a signiﬁcant high dose of total ephedrine
administrated when compared to ketamine and dexamethaz-
one groups (8 ± 3.2 versus 4.5 ± 2.1 in ketamine group, and
5.3 ± 2 in dexamethazone group), and a signiﬁcant high rate
of hypotensive episodes when compared to ketamine group
(84.4% versus 64%) (Table 2). There was statistically insignif-
icant increase in the rate of successful prevention of IONV in
ketamine group when compared to dexamethazone group
(77.8% versus 71.2%). The incidence of only nausea (13.3%
with ketamine versus 17.7% with dexamethazone), and the
incidence of only vomiting (8.9% with ketamine versus
11.1% with dexamethazone) were statistically insigniﬁcant
when compared between both groups. The total incidence of
intraoperative nausea and vomiting was 22.2% in the ketamine
group compared with 28.8% in the dexamethazone group,
which was statistically insigniﬁcant. The number of patients
who required rescue antiemetics in the ketamine group com-
pared with dexamethazone group (6.7% versus 8.8%;
P= 0.69) was not statistically signiﬁcant. The control group
showed a signiﬁcant high incidence of IONV (51.1%) and a
signiﬁcant low incidence of successful prevention of IONV
(48.9%) when compared to ketamine or dexamethazone group
(Table 3). There was a signiﬁcant increase in Ramsey sedation
score in ketamine group when compared to dexamethazone
Table 1 Baseline maternal characteristics.
Variable Ketamine group
(n= 45)
Dexamethasone group
(n= 45)
Control group
(n= 45)
P-value
P1 P2 P3
Age (years) 29.4 ± 7.2 28.5 ± 5.3 30 ± 6 0.50 0.66 0.21
Weight (kg) 72 ± 9 73 ± 11 69 ± 13 0.63 0.20 0.11
Height (cm) 163 ± 4 164.2 ± 5 162 ± 6.5 0.21 0.38 0.07
Gestational age (weeks) 38.2 ± 1.5 38.4 ± 1.3 38 ± 1.7 0.50 0.55 0.21
History of PONV 4 (8.8%) 6 (13.3%) 3 (6.7%) 0.53 0.69 0.29
History of vertigo 3 (6.7%) 2 (4.4%) 4 (8.8%) 0.64 0.69 0.39
Baseline mean arterial blood
pressure (mmHg)
85 ± 8.2 83 ± 7.3 85 ± 9 0.22 1 0.25
Baseline heart rate (pbm) 76.4 ± 8.7 77.2 ± 9 76 ± 11 0.66 0.84 0.57
P1: Ketamine versus dexamethazone. P2: Ketamine versus control. P3: Dexamethazone versus control.
Table 2 Operative details.
Variable Ketamine group
(n= 45)
Dexamethasone group
(n= 45)
Control group
(n= 45)
P-value
P1 P2 P3
Anesthesia time (min) 65 ± 19 63 ± 21 65 ± 23 0.63 1 0.66
Operative time (min) 52 ± 20 54 ± 18 55 ± 19 0.61 0.46 0.79
Total ephedrine
administered (mg)
4.5 ± 2.1 5.3 ± 2 8 ± 3.2 0.06 0.003* 0.008*
Total fentanyl
administered (lg)
28.3 ± 5.2 28.5 ± 4.6 30 ± 5.5 0.84 0.13 0.16
Hypotensive episodes 29 (64%) 33 (73%) 38 (84.4%) 0.36 0.02* 0.19
Sensory block T4 (%) 21 (46.7%) 19 (42.2%) 20 (44.4%) 0.67 0.83 0.83
P1: Ketamine versus dexamethazone. P2: Ketamine versus control. P3: Dexamethazone versus control.
* Signiﬁcant difference.
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incision (Table 4). The studied groups were comparable as
regard to mean arterial blood pressure and heart rate, there
was no statistically signiﬁcant difference between groups dur-
ing the study period (Figs. 1 and 2), also the studied groups
were comparable as regard to the highest sensory level reached
after spinal injection (T4) and the remaining not below (T10).4. Discussion
IONV is distressing for patients, obstetricians, anesthetists,
and may increase the risk of visceral injury during surgery
by involuntary uncontrolled abdominal movements. The pre-
cise etiology of IONV remains unknown and various factors
have been implicated [10]. Hypotension is probably the most
important cause of IONV that occurs during CS under spinal
anesthesia. Hypotension can induce the emetic symptoms by
leading to cerebral hypoperfusion [11]. Prevention of hypoten-
sion is therefore important for the prevention of IONV. We
tried to take the necessary measures to prevent hypotension
in all of our patients by preload, left uterine tilt, increasing rate
of ﬂuid infusion and increments of ephedrine when necessary.
Our double blind study demonstrated that CSs performed
under spinal anesthesia using 0.4 mg ketamine as a single agent
for the control of IONV is as effective as 8 mg intravenous
dexamethasone with no increase in the side effect proﬁle.
The mechanism for the antiemetic effect of dexamethasone
has been incompletely understood but it is thought to becaused by the inhibition of prostaglandin synthesis, by show-
ing anti-inﬂammatory efﬁcacy and by causing a decrease in
the release of endogenous opiates [6,7]. Several studies investi-
gates different medications to reduce IONV in parturients
undergoing CS under spinal anesthesia, Fujii and his col-
leagues [12] investigated the preventive effect of IV granisetron
3 mg, some studies compared the antiemetic efﬁcacy of dexa-
methasone for the prevention of PONV with other agents, or
the efﬁcacy of combining metoclopropamide 10 mg, droperi-
dol 1.25 mg against placebo; they found that the three drugs
were similarly effective in reduction of intraoperative nausea
compared to placebo effect (P value = 0.001). dexamethasone
with other antiemetic agents for the same purpose. D’Souza
et al. compared dexamethasone with ondansetron for the pre-
vention of PONV after laparoscopic gynecologic surgery and
found that dexamethasone decreased the incidence of PONV
and use of single dose of dexamethasone was safe and could
be alternative to single dose ondansetron [13]. In agreement
of previous studies our study demonstrates signiﬁcant reduc-
tion in IONV in dexamethasone group than placebo (P
value = 0.03). Ketamine is an intravenous dissociative anes-
thetic agent related to phencyclidine group which works by
antagonizing N-methyl D-aspartate (NMDA) receptors [8].
Few studies examined the effect of a ketamine on the incidence
of nausea and vomiting during cesarean section by spinal
anesthesia The sympatho-mimetic and vagolytic properties of
ketamine encouraged us to examine its effects on IONV and
compare it to dexamethasone which examined by many
author. Ure D, et al. studied the effect of glycopyrolate in
Table 4 Ramsey sedation score (RSS) in the studied groups.
Time (min) RSS score Ketamine group (n= 45) Dexamethasone group (n= 45) Control group (n= 45) P-value
P1 P2 P3
5 2 40 (88.9%) 42 (93.3%) 43 (95.9%) 0.45 0.23 0.64
3 5 (11.1%) 3 (6.7%) 2 (4.4%)
10 2 35 (77.8%) 43 (95.6%) 44 (97.8%) 0.04* 0.01* 0.55
3 9 (20%) 2 (4.4%) 1 (2.2%)
4 1 (2.2%) 0 (0%) 0 (0%)
20 2 35 (77.8%) 44 (97.8%) 45 (100%) 0.003* 0.0007* 0.31
3 10 (22.2%) 1 (2.2%) 0 (0%)
30 2 40 (88.9%) 45 (100%) 45 (100%) 0.02* 0.02* 1
3 5 (11.1%) 0 (0%) 0 (0%)
P1: Ketamine versus dexamethazone. P2: Ketamine versus control. P3: Dexamethazone versus control.
* Signiﬁcant difference.
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Figure 1 Intraoperative mean arterial blood pressure (MAP) of
the studied groups.
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Figure 2 Intraoperative heart rate (HR) of the studied groups.
Table 3 Comparison of the emetic symptoms during intraoperative period in the studied groups.
Variable Ketamine group
(n= 45)
Dexamethazone
group (n= 45)
Control group
(n= 45)
P-value
P1 P2 P3
No intraoperative nausea or vomiting
(successful prevention)
35 (77.8%) 32 (71.2%) 22 (48.9%) 0.46 0.004* 0.03*
Incidence of nausea 6 (13.3%) 8 (17.7%) 13 (28.9%) 0.56 0.07 0.21
Incidence of vomiting 4 (8.9%) 5 (11.1%) 9 (20%) 0.72 0.13 0.24
Total intraoperative nausea and
vomiting
10 (22.2%) 13 (28.8%) 23 (51.1%) 0.46 0.004* 0.03*
Rescue antiemetics 4 (8.9%) 5 (11.1%) 9 (20%) 0.72 0.13 0.24
P1: Ketamine versus dexamethazone. P2: Ketamine versus control. P3: Dexamethazone versus control.
* Signiﬁcant difference.
62 A. Hassanein, E. Mahmoudprevention of intraoperative nausea during CS relying on its
vagolytic effect, the incidence of IONV reduced from 68% in
the placebo group to 42% in the glycopyrolate group [14]. Sha-
bana et al. studied the effect of 0.5 mg/kg ketamine on IONV,they showed signiﬁcant reduction (P value 0.004) in nausea in
the ketamine group compared with placebo group, also
showed statistically insigniﬁcant reduction in vomiting in ket-
amine versus placebo group (2.3% versus 4.6%) [15], and the
majority of hypotensive episodes occurs during the infusion
time of ketamine. In our study we started by three pilot cases
of 0.5 mg/kg ketamine injection but we found RSS of the three
cases is 4 in ﬁrst 10 min, we reduced the dose of ketamine to
0.4 mg/kg to avoid high RSS, shorten the duration of drug
infusion and avoid any side effects. In agreement to our view
some blood-borne toxins and drugs stimulate an area in the
medulla which is called chemoreceptor trigger zone (CTZ).
This zone communicates with the vomiting center, to initiate
vomiting [9]. It should be noted that if the CTZ was stimu-
lated, its deactivation would be difﬁcult [10], so we decided
to start injection of studied drugs early, in contrast to many
lecturers that started antiemetics after umbilical cord clamp-
ing. In our study the rate of successful prevention of IONV
in ketamine group when compared to dexamethazone group
(77.8% versus 71.2%) which was statistically insigniﬁcant,
but signiﬁcant reduction in both groups when compared with
control group (48.9%). Total amount of ephedrine and hypo-
tensive episodes was greater in control group than in studied
drugs, and the hypotensive episodes in ketamine group insig-
niﬁcantly less than in dexamethasone group because of sym-
pathomimetic and vagolytic effect of ketamine. There was a
signiﬁcant increase in Ramsey sedation score in ketamine
group when compared to dexamethazone group and control
Effect of low dose ketamine versus dexamethasone on intraoperative nausea and vomiting during caesarean section 63group at 10, 20 and 30 min after surgical incision, only one
parturient in ketamine group gain RSS 4 at 10 min. In conclu-
sion; the current study demonstrated that direct IV ketamine
0.4 mg/kg is effective as 8 mg dexamethasone in prevention
of IONV in parturients subjected to elective CS under spinal
anesthesia and associated with reduction in the incidence of
hypotensive episodes compared to placebo group.
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